Cynata Therapeutics Ltd (CYP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.969x

Based on the latest financial reports, Cynata Therapeutics Ltd (CYP) has a cash flow conversion efficiency ratio of -0.969x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.79 Million ≈ $-4.10 Million USD) by net assets (AU$5.98 Million ≈ $4.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cynata Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Cynata Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cynata Therapeutics Ltd (CYP) financial obligations for a breakdown of total debt and financial obligations.

Cynata Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cynata Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Regis Corporation Common Stock NYSE:RGS	0.009x
CUROCOM Co. Ltd KQ:040350	0.017x
ADAMA Ltd B SHE:200553	0.103x
Inspirato Inc NASDAQ:ISPO	0.016x
Rushil Decor Limited NSE:RUSHIL	0.044x
Leader Electronics Inc TW:3058	-0.212x
Speciality Restaurants Limited NSE:SPECIALITY	0.095x
Evrofarma SA AT:EVROF	-0.018x

Annual Cash Flow Conversion Efficiency for Cynata Therapeutics Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Cynata Therapeutics Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cynata Therapeutics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.98 Million ≈ $4.23 Million	AU$-8.72 Million ≈ $-6.17 Million	-1.458x	-5.63%
2024-06-30	AU$7.22 Million ≈ $5.11 Million	AU$-9.96 Million ≈ $-7.05 Million	-1.380x	-61.69%
2023-06-30	AU$16.73 Million ≈ $11.84 Million	AU$-14.28 Million ≈ $-10.11 Million	-0.854x	-520.04%
2022-06-30	AU$23.96 Million ≈ $16.95 Million	AU$-3.30 Million ≈ $-2.33 Million	-0.138x	+24.35%
2021-06-30	AU$28.37 Million ≈ $20.08 Million	AU$-5.16 Million ≈ $-3.65 Million	-0.182x	+9.81%
2020-06-30	AU$16.79 Million ≈ $11.88 Million	AU$-3.39 Million ≈ $-2.40 Million	-0.202x	+67.25%
2019-06-30	AU$10.97 Million ≈ $7.76 Million	AU$-6.76 Million ≈ $-4.78 Million	-0.616x	-133.37%
2018-06-30	AU$15.39 Million ≈ $10.89 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.264x	+9.59%
2017-06-30	AU$13.86 Million ≈ $9.81 Million	AU$-4.05 Million ≈ $-2.86 Million	-0.292x	+42.44%
2016-06-30	AU$8.58 Million ≈ $6.07 Million	AU$-4.35 Million ≈ $-3.08 Million	-0.507x	-70.56%
2015-06-30	AU$8.75 Million ≈ $6.19 Million	AU$-2.60 Million ≈ $-1.84 Million	-0.297x	-58.11%
2014-06-30	AU$9.85 Million ≈ $6.97 Million	AU$-1.85 Million ≈ $-1.31 Million	-0.188x	+59.64%
2013-06-30	AU$1.64 Million ≈ $1.16 Million	AU$-765.76K ≈ $-541.83K	-0.466x	+45.44%
2012-06-30	AU$853.75K ≈ $604.08K	AU$-729.33K ≈ $-516.05K	-0.854x	+68.73%
2011-06-30	AU$971.93K ≈ $687.70K	AU$-2.66 Million ≈ $-1.88 Million	-2.732x	-30.36%
2010-06-30	AU$932.00K ≈ $659.45K	AU$-1.95 Million ≈ $-1.38 Million	-2.096x	-65.58%
2009-06-30	AU$961.98K ≈ $680.66K	AU$-1.22 Million ≈ $-861.47K	-1.266x	-94.87%
2008-06-30	AU$2.21 Million ≈ $1.56 Million	AU$-1.44 Million ≈ $-1.02 Million	-0.649x	--

About Cynata Therapeutics Ltd

AU:CYP Australia Biotechnology

Market Cap

$54.18 Million

AU$76.58 Million AUD

Market Cap Rank

#21588 Global

#776 in Australia

Share Price

AU$0.32

Change (1 day)

+0.00%

52-Week Range

AU$0.15 - AU$0.40

All Time High

AU$1.84